Subscribe
  • Home
  • Issues
    • Online First
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • Value-Based Care in Myeloma

Monique Hartley-Brown, MD, MMSc

Medical Oncologist, Department of Medicine
Member of Faculty, Harvard Medical School
Attending Physician, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

Authored Articles

Use of Isatuximab as Early Therapy in Patients with Multiple Myeloma
Monique Hartley-Brown, MD, MMSc, Paul G. Richardson, MD
Faculty Perspectives: Optimizing Clinical Outcomes and Value-Based Management in Multiple Myeloma—The Role of Isatuximab
Read Article
Studying the Use of Novel Therapies in Various Multiple Myeloma Disease Settings
Monique Hartley-Brown, MD, MMSc, Paul G. Richardson, MD
Faculty Perspectives: The Evolving Clinical and Pharmacoeconomic Impact of Isatuximab in Multiple Myeloma Management
Read Article

Top Trending Articles

1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
  • Home
  • Issues
    • Online First
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • Value-Based Care in Myeloma
Subscribe

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
  • About
  • About VBCC
  • Mission Statement
  • Advertising
  • Contact
  • Contribute
  • Submit a Manuscript
  • Editorial / Publishing Policies
  • Author Guidelines
  • Publications
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Cholangiocarcinoma News
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.